Connect with us

Hi, what are you looking for?

Medicine

Why Did Cassava Sciences Stock Jump 49% Today?

Journal of Neuroscience has informed Cassava Sciences Inc (NASDAQ: SAVA) that there is no evidence of data manipulation in an article published in July 2012 describing a new approach to treating Alzheimer’s disease. 
The peer-reviewed article was co-authored by scientists and academic collaborators for Cassava Sciences and is foundational to simufilam, the Company’s …

Full story available on Benzinga.com

Source: benzinga.com

Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Medicine

Arbutus’ Lead Compound AB-729 Continues to be Safe and Effective at Reducing HBsAg in Patients with Chronic Hepatitis B HBsAg remains suppressed up to...

Medicine

PHILADELPHIA, Nov. 09, 2021 (GLOBE NEWSWIRE) — AnPac Bio-Medical Science Co., Ltd. (NASDAQ:ANPC, the “Company”)), a biotechnology company with operations in China and the...

Medicine

COVID passes and vaccine passports may promise the ideal solution to avoiding further lockdowns in the UK or pose a threat to people’s freedoms...

Arts

The Fourth Single ‘Eyy Bidda Idhi Naa Adda’ From Allu Arjun’s Pushpa Is Out… The Fourth Single ‘Eyy Bidda Idhi Naa Adda’ From Allu...

ONBP.com